[2-(acetamidomethyl)-4-[1-(difluoromethyl)-3-ethoxypyrazol-4-yl]sulfonyl-2,3-dihydro-1,4-benzoxazin-6-yl]carbamic acid
C18H21F2N5O7S — CID 122616215
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(acetamidomethyl)-4-[1-(difluoromethyl)-3-ethoxypyrazol-4-yl]sulfonyl-2,3-dihydro-1,4-benzoxazin-6-yl]carbamic acid
[2-(acetamidomethyl)-4-[1-(difluoromethyl)-3-ethoxypyrazol-4-yl]sulfonyl-2,3-dihydro-1,4-benzoxazin-6-yl]carbamic acid (PubChem CID 122616215) has the molecular formula C18H21F2N5O7S and a molecular weight of 489.46 g/mol. Its IUPAC name is [2-(acetamidomethyl)-4-[1-(difluoromethyl)-3-ethoxypyrazol-4-yl]sulfonyl-2,3-dihydro-1,4-benzoxazin-6-yl]carbamic acid.
Molecular Properties
| Compound Name | [2-(acetamidomethyl)-4-[1-(difluoromethyl)-3-ethoxypyrazol-4-yl]sulfonyl-2,3-dihydro-1,4-benzoxazin-6-yl]carbamic acid |
|---|---|
| PubChem CID | 122616215 |
| Molecular Formula | C18H21F2N5O7S |
| Molecular Weight | 489.46 g/mol |
| Exact Mass | 489.11 |
| IUPAC Name | [2-(acetamidomethyl)-4-[1-(difluoromethyl)-3-ethoxypyrazol-4-yl]sulfonyl-2,3-dihydro-1,4-benzoxazin-6-yl]carbamic acid |
| SMILES | CCOc1nn(C(F)F)cc1S(=O)(=O)N1CC(CNC(C)=O)Oc2ccc(NC(=O)O)cc21 |
| InChI | InChI=1S/C18H21F2N5O7S/c1-3-31-16-15(9-24(23-16)17(19)20)33(29,30)25-8-12(7-21-10(2)26)32-14-5-4-11(6-13(14)25)22-18(27)28/h4-6,9,12,17,22H,3,7-8H2,1-2H3,(H,21,26)(H,27,28) |
| InChIKey | JJEQKDSUWJQMIM-UHFFFAOYSA-N |
| XLogP | 1.86 |
| TPSA | 152.09 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.46 |
| LogP ≤ 5 | 1.86 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122616215 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.